Sponsored Symposia



Wednesday 2nd of March 2016

11:30

AFFARI 1 Sponsored Round Table 11:30 → 13:00
Effective communication skills and treatment options for women with menopausal symptoms (Sponsored by Pfizer)

  • Genazzani Andrea R. (IT) .
  • Nappi Rossella E. (IT) .
  • Kingsberg Sheryl (US) .

15:40

AUDITORIUM Sponsored Opening Symposium 15:40 → 17:10
Innovative treatment options in Menopause

Chairperson/s: Genazzani Andrea R. (IT), Benedetto Chiara (IT)

  • Palacios Santiago (ES) Limitations of current menopause therapies: the unmet need
  • Egarter Christian (AT) The new paradigm for menopausal therapy: tissue selective estrogen complex (TSEC)
  • Goldstein Steven (US) Clinical overview of conjugated estrogens/bezadoxifene
  • Skouby Sven (DK) Where the TSEC fits in clinical practice?

Thursday 3rd of March 2016

11:45

AUDITORIUM Sponsored Symposium 11:45 → 13:15
The latest innovation in hormonal contraception – clinical trial data about the gestodene containing transdermal patch (Sponsored by Gedeon Richter)

Chairperson/s: Fruzzetti Franca (IT)

  • Nappi Rossella E. (IT) Hormonal Contraception- Past and Future
  • Paszkowski Tomasz (PL) Transdermal Contraception – The latest trial data
  • Rabe Thomas (DE) Gestodene containing new transdermal contraceptive patch –from backstage to frontline

13:30

AFFARI 1 Sponsored Lunch Symposium 13:30 → 15:15
The premisses of pregnancy (sponsored by IBSA)

Chairperson/s: Barri Pedro (ES), de Ziegler Dominique (FR)

  • De Seta Francesco (IT) The Microbiota, Uterus and Pregnancy
  • Griesinger Georg (DE) Lessons learned from the phase III trials on subcutaneous progesterone
  • Brosens Ivo (BE) Quality of placentation and obstetrical outcome

AFFARI 2 Sponsored Lunch Symposium 13:30 → 15:15
A new breakthrough in non hormonal climacteric symptoms treatment (sponsored by SERELYS Pharma))

Chairperson/s: Palacios Santiago (ES), Druckmann René (FR)

  • Palacios Santiago (ES) Production and Biotechnology of the Purified and Specific Cytoplasm of Pollen
  • Rozenberg Serge (BE) Clinical proof of efficacy and safety
  • Goldstein Steven (US) Treatment of VMS in Breast Cancer Patients
  • Genazzani Andrea R. (IT) Mechanism of Action
  • Lachowksy Michèle (FR) Quality of life – Conclusions

16:45

AFFARI 1 Sponsored Satellite Symposium 16:45 → 18:15
Premature ejaculation (PE) : the two sides of the same coin (sponsored by MENARINI Group)

Chairperson/s: Genazzani Andrea R. (IT), Graziottin Alessandra (IT)

  • Graziottin Alessandra (IT) Woman perspective: The female sexual dysfunctions (FSD) related to male’s PE
  • Reisman Yacov (NL) Man perspective: Patient’s behavior and pharmacological solutions
  • Tripodi Francesca (IT) The couple psychological assessment: The daily clinician’s experience in the treatment of PE

18:15

AFFARI 1 ISGE General Assembly 18:15 → 19:15
ISGE General Assembly

Friday 4th of March 2016

09:45

AFFARI 1 Sponsored Symposium 09:45 → 11:15
Clinical management of women with hyperandrogenic symptoms . A case-based discussion from multidisciplinary experts (sponsored by BAYER)

Chairperson/s: Bitzer Johannes (CH)

  • Zouboulis Christos (DE) Scientific basis of acne and hirsutism
  • KUBBA ALI (GB) Optimizing treatment outcomes

11:45

AFFARI 1 Sponsored Symposium 11:45 → 13:15
Oral contraception: #2bleedornot2bleed ? (sponsored by TEVA)

Chairperson/s: Nappi Rossella E. (IT), Bitzer Johannes (CH)

  • Azoulay Catherine (FR) #Freeperiods – Monthly bleeding: useful or not ?
  • Nappi Rossella E. (IT) #Itsabouttime – What do doctors think ?
  • Fiala Christian (AT) #Itcostme- What do women want ?
  • Lobo Paloma (ES) #Lessperiodsmorelove – Reducing number of the periods: are there other potential benefits?
  • Nappi Rossella E. (IT) #Less4more – Take Home messages – Conclusion

AFFARI 2 Sponsored Symposium 11:45 → 13:15
Modern management of uterine fibroids with Ulipristal Acetate (UPA) (sponsored by GEDEON RICHTER)

Chairperson/s: Petraglia Felice (IT)

  • Bouchard Philippe (FR) Mode of action of Ulipristal Acetate
  • Fauser Bart C. (NL) Endocrine and metabolic profile after long term exposure to UPA
  • Donnez Jaques (BE) From fibroid volume reduction to pregnancies: the in vivo mechanism of UPA

16:30

AFFARI 2 Sponsored Symposium 16:30 → 18:00
New physiological treatment of vulvovaginal atrophy of menopause (sponsored by ENDOCEUTICS)

Chairperson/s: Genazzani Andrea R. (IT), Palacios Santiago (ES)

  • Simoncini Tommaso (IT) Local formation of sex steroids following intravaginal DHEA: intracrinology at work
  • Archer David (US) Efficacy of intravaginal prasterone (DHEA) on the vulvovaginal atrophy signs and symptoms
  • Nappi Rossella E. (IT) The clinical pictures of vulvovaginal atrophy(VVA)



Supporters from the industry

The International Society of Gynecological Endocrinology as well as the Associazione Italiana di Ginecologia Endocrinologica, are grateful to the following companies for their support to the societies’ activities and/or congresses

sponsors-list